ATE423554T1 - Hydratisierende zusammensetzung - Google Patents

Hydratisierende zusammensetzung

Info

Publication number
ATE423554T1
ATE423554T1 AT05763000T AT05763000T ATE423554T1 AT E423554 T1 ATE423554 T1 AT E423554T1 AT 05763000 T AT05763000 T AT 05763000T AT 05763000 T AT05763000 T AT 05763000T AT E423554 T1 ATE423554 T1 AT E423554T1
Authority
AT
Austria
Prior art keywords
water
compositions
increasing
methods
creatine
Prior art date
Application number
AT05763000T
Other languages
English (en)
Inventor
Yannis Paul Pitsiladis
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Application granted granted Critical
Publication of ATE423554T1 publication Critical patent/ATE423554T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT05763000T 2004-07-23 2005-07-25 Hydratisierende zusammensetzung ATE423554T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59045304P 2004-07-23 2004-07-23
GBGB0416493.5A GB0416493D0 (en) 2004-07-23 2004-07-23 Hydrating composition

Publications (1)

Publication Number Publication Date
ATE423554T1 true ATE423554T1 (de) 2009-03-15

Family

ID=32922705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763000T ATE423554T1 (de) 2004-07-23 2005-07-25 Hydratisierende zusammensetzung

Country Status (7)

Country Link
US (1) US20070249559A1 (de)
EP (1) EP1778205B1 (de)
AT (1) ATE423554T1 (de)
CA (1) CA2615966A1 (de)
ES (1) ES2322769T3 (de)
GB (1) GB0416493D0 (de)
WO (1) WO2006008552A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2156188B1 (de) 2007-03-28 2021-05-05 University of Southern California Induktion differentieller stressresistenz und verwendungen davon
JP2011523626A (ja) * 2008-04-24 2011-08-18 ユニバーシティー オブ サウザン カリフォルニア，ユーエスシー スティーブンズ 化学療法、放射線療法、酸化ストレス、および加齢を防御するための食事組成物ならびに方法
EP2145621A1 (de) * 2008-07-16 2010-01-20 Stephan Lück Verhinderung der Dehydrierung und Reduzierung der gluconeogenetischen Verluste von Aminosäuren durch Propan-1,2,3-Triol
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
WO2011143534A1 (en) * 2010-05-13 2011-11-17 The Mclean Hospital Corporation Methods for the treatment of psychiatric disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236712A (en) * 1988-07-29 1993-08-17 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US5403921A (en) * 1993-04-30 1995-04-04 University Of New Mexico Exercise hydration regimen to enhance exercise endurance and performance
US5811600A (en) * 1993-04-30 1998-09-22 University Of New Mexico Glycerol enhanced rehydration formulation
GB9402950D0 (en) * 1994-02-16 1994-04-06 Univ Leeds Innovations Ltd Sports drink
US5777343A (en) * 1996-05-08 1998-07-07 The Columbiana Boiler Company Uranium hexafluoride carrier
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US5876763A (en) * 1998-05-26 1999-03-02 University Of New Mexico Glycerol enhanced rehydration formulation
US6485764B2 (en) * 2000-01-25 2002-11-26 Robert A. Robergs Hydrating beverages and method
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
JP2004123686A (ja) * 2002-10-02 2004-04-22 Crescendo Corporation 熱中症予防

Also Published As

Publication number Publication date
EP1778205A1 (de) 2007-05-02
EP1778205B1 (de) 2009-02-25
CA2615966A1 (en) 2006-01-26
ES2322769T3 (es) 2009-06-26
US20070249559A1 (en) 2007-10-25
WO2006008552A1 (en) 2006-01-26
GB0416493D0 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
EA200701661A1 (ru) Композиция активного вещества
TW200640475A (en) Cosmetic and cosmeceutical compositions for restoration of skin barrier function
EA201190286A1 (ru) Адъювантные композиции, содержащие неионный агент, обеспечивающий изотоничность
AR046933A1 (es) Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea
WO2005046360A3 (en) Carbohydate and electrolyte replacement composition
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
EA201100079A1 (ru) Производные триазоло[4,5-d]пирамидина и их применение в качестве антагонистов пуринового рецептора
BRPI0411547A (pt) composição de tratamento na lavagem de roupa
EA200801859A1 (ru) Неводная композиция стабильного витамина "c", способ ее приготовления и применения
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
ATE484508T1 (de) Furylverbindungen
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
MX2009003378A (es) Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos.
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA201000550A1 (ru) Производные тиазола
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
UA87627C2 (ru) Фармацевтическая композиция в виде тестостеронового геля и ее использование при лечении гипогонадизма у мужчин
EA200800595A1 (ru) Композиции политиоуретана и способы получения и применения композиций политиоуретана
EA200970587A1 (ru) Состав
ATE423554T1 (de) Hydratisierende zusammensetzung
EA201000432A1 (ru) Фунгицидные смеси тритиконазола и дифеноконазола
WO2007025166A3 (en) Devices, compositions and methods for the protection and repair of cells and tissues
BR0300096A (pt) Polìmero, processo de preparação de polìmeros, uso de pelo menos um polìmero e composição
EA201170269A1 (ru) Композиция для предотвращения или замедления развития рака предстательной железы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties